Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 412.5 GBX -1.43% Market Closed
Market Cap: 434.6m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

Oxford BioMedica PLC
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Oxford BioMedica PLC
Long-Term Debt Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Oxford BioMedica PLC
LSE:OXB
Long-Term Debt
ÂŁ105.5m
CAGR 3-Years
128%
CAGR 5-Years
67%
CAGR 10-Years
59%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Long-Term Debt
$75.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Long-Term Debt
ÂŁ48m
CAGR 3-Years
-8%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Long-Term Debt
ÂŁ272.3m
CAGR 3-Years
28%
CAGR 5-Years
21%
CAGR 10-Years
14%

See Also

What is Oxford BioMedica PLC's Long-Term Debt?
Long-Term Debt
105.5m GBP

Based on the financial report for Jun 30, 2024, Oxford BioMedica PLC's Long-Term Debt amounts to 105.5m GBP.

What is Oxford BioMedica PLC's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
59%

Over the last year, the Long-Term Debt growth was -4%. The average annual Long-Term Debt growth rates for Oxford BioMedica PLC have been 128% over the past three years , 67% over the past five years , and 59% over the past ten years .

Back to Top